INCY:NASDAQ
Incyte
121,47Â US$
arrow_downward
-1,47%(-1,81) 1K
119,64Â US$
arrow_downward
-1,51% (-1,83)bedtimeYopilgandan keyin
Savdolar yopilgan: 11-sen, 16:00:01 (GMT-4) · USD
search
Barcha belgilar
1K
5K
1O
6O
YBB
1Y
5Y
MAKS
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoINCY tikeri uchun statistika yaratilmoqda...
Ochish
124,35Â US$
Yuqori
124,35Â US$
Past
121,42Â US$
Bozor kapitali
24,62Â mlrd
Oʻrtacha hajm
1,40Â mln
Hajmi
1,43Â mln
P/E koeffitsiyenti
15,48
52 haftalik eng yuqori
132,58Â US$
52 haftalik eng past
81,09Â US$
Aksiya boʻyicha daromad
7,85Â US$
Beta
0,77
Muomaladagi aksiyalar
202,70Â mln
Xodimlar soni
3Â ming
Ochish
124,35Â US$
Yuqori
124,35Â US$
Past
121,42Â US$
Bozor kapitali
24,62Â mlrd
Oʻrtacha hajm
1,40Â mln
Hajmi
1,43Â mln
P/E koeffitsiyenti
15,48
52 haftalik eng yuqori
132,58Â US$
52 haftalik eng past
81,09Â US$
Aksiya boʻyicha daromad
7,85Â US$
Beta
0,77
Muomaladagi aksiyalar
202,70Â mln
Xodimlar soni
3Â ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
ad-hoc-news.de
·
1 kun oldin
Incyte stock gains institutional support as shares trade near 52-week high
Benzinga
·
1 kun oldin
Here's How Much $1000 Invested In Incyte 20 Years Ago Would Be Worth Today
Investor's Business Daily
·
1 kun oldin
Profitable Biotech Incyte Stock Forms Handle Amid Strong Institutional Accumulation
Profil
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity. Wikipedia
Incyte haqida
CEOHervé Hoppenot
Xodimlar soni2,84Â ming
Asos solingan2002
Bosh ofislarWilmington, Delaver, Amerika Qo‘shma Shtatlari
Sektor-
Veb-saytincyte.com